General Text Left
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer ex lorem, portavitae pulvinar id, suscipit eu augue. Nulla neque est, ullamcorper eu elementumin, varius laoreet tortor. Duis sed consectetur ligula, tempus aliquam nunc.Quisque at sodales est. Ut tristique convallis orci, eu rhoncus nisl. Nullam pretiumpharetra elit vitae bibendum. Nullam odio nulla, varius sed aliquet vel, aliqueteget tortor. Pellentesque habitant morbi tristique senectu
General Text Right
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer ex lorem, portavitae pulvinar id, suscipit eu augue. Nulla neque est, ullamcorper eu elementumin, varius laoreet tortor. Duis sed consectetur ligula, tempus aliquam nunc.Quisque at sodales est. Ut tristique convallis orci, eu rhoncus nisl. Nullam pretiumpharetra elit vitae bibendum. Nullam odio nulla, varius sed aliquet vel, aliqueteget tortor. Pellentesque habitant morbi tristique senectu
SGC Board
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Jim Brown
Affiliation
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Dr. Anke Mueller-Fahrnow
ICB Nuvisan
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Jams Bond
ManagerSGC Management Team
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Jim Brown
Affiliation
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Dr. Anke Mueller-Fahrnow
ICB Nuvisan
Dr. Anke Mueller-Fahrnow is the chair of the SGC Board of Directors, and the chair of the Conscience Board of Directors and she works as an independent consultant for a German CRO, Nuvisan ICB GmbH. Trained as a biochemist and structural biologist at the Free University of Berlin, her research interests include drug discovery with a strong focus on lead discovery, mostly in the areas of oncology and women’s health. She has published close to 50 scientific publications.
Jams Bond
Manager-
Support for Disease -Specfic Research
-
Democratizing Drug Discouvery
How You Can Contribute
Support for Democratizing - Specific Discouvery
Many proteins linked to common and rare diseases remain unexplored. We leverage our expertise to uncover their functions and have seen promising results in clinical trials. If you represent a disease foundation or are driven by a specific health condition, consider directing your support towards research on a protein of interest. Your targeted donation can launch new projects that may lead to breakthrough therapies.
Democratizing Drug Discouvery
Many proteins linked to common and rare diseases remain unexplored. We leverage our expertise to uncover their functions and have seen promising results in clinical trials. If you represent a disease foundation or are driven by a specific health condition, consider directing your support towards research on a protein of interest. Your targeted donation can launch new projects that may lead to breakthrough therapies.
Contacts:
Claudia Gordijo, PhD
Associate Director, Strategic Initiatives and Partnerships